Is BRCA mutation screening a cost-effective strategy to improve targeted therapy in serous epithelial ovarian cancer?J. Scalici,J. Straughn,J. Estes,C. Leath,M. Finan, R. RocconiGynecologic Oncology(2013)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要